{"entity":{"type":"insider","cik":"0001805812","url":"/insider/0001805812","json_url":"/insider/0001805812.json","name":"Jacobson Mark L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":9,"first":"2024-04-01","last":"2026-05-05","span_basis":"filed_date"},"name_variants":[{"name":"Jacobson Mark L.","source":"filing","n_filings":9,"first_seen":"2024-04-01","last_seen":"2026-05-05"}],"transactions":[{"id":5762959,"accession":"0001193125-26-207148","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-207148","line_url":"/filing/0001193125-26-207148#line-4","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001805812","owner_name":"Jacobson Mark L.","owner_display_name":"Jacobson Mark L.","owner_url":"/insider/0001805812","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233.0,"shares_display":"233","price_per_share":228.18,"price_display":"228.18","price_state":"stated","total_value":53165.94,"total_display":"53,165.94","total_whole":"53,166","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-05","scope":"insider"},{"id":5762955,"accession":"0001193125-26-207148","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-207148","line_url":"/filing/0001193125-26-207148#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001805812","owner_name":"Jacobson Mark L.","owner_display_name":"Jacobson Mark L.","owner_url":"/insider/0001805812","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4517.0,"shares_display":"4,517","price_per_share":227.94,"price_display":"227.94","price_state":"stated","total_value":1029604.98,"total_display":"1,029,604.98","total_whole":"1,029,605","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-05","scope":"insider"},{"id":5929746,"accession":"0001193125-26-083586","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-083586","line_url":"/filing/0001193125-26-083586#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001805812","owner_name":"Jacobson Mark L.","owner_display_name":"Jacobson Mark L.","owner_url":"/insider/0001805812","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35378.0,"shares_display":"35,378","price_per_share":161.88,"price_display":"161.88","price_state":"stated","total_value":5726990.64,"total_display":"5,726,990.64","total_whole":"5,726,991","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-26","filed_date":"2026-02-27","scope":"insider"},{"id":4270634,"accession":"0001193125-25-211788","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-211788","line_url":"/filing/0001193125-25-211788#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001805812","owner_name":"Jacobson Mark L.","owner_display_name":"Jacobson Mark L.","owner_url":"/insider/0001805812","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":115.96,"price_display":"115.96","price_state":"stated","total_value":1159600.0,"total_display":"1,159,600.00","total_whole":"1,159,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-22","filed_date":"2025-09-22","scope":"insider"},{"id":4135203,"accession":"0001193125-25-206494","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-206494","line_url":"/filing/0001193125-25-206494","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001805812","owner_name":"Jacobson Mark L.","owner_display_name":"Jacobson Mark L.","owner_url":"/insider/0001805812","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45783.0,"shares_display":"45,783","price_per_share":114.47757399034576,"price_display":"114.48","price_state":"stated","total_value":5241126.77,"total_display":"5,241,126.77","total_whole":"5,241,127","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-16","filed_date":"2025-09-17","scope":"insider","n_lines":2},{"id":4661875,"accession":"0000950170-25-084556","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-084556","line_url":"/filing/0000950170-25-084556#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001805812","owner_name":"Jacobson Mark L.","owner_display_name":"Jacobson Mark L.","owner_url":"/insider/0001805812","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":110.44,"price_display":"110.44","price_state":"stated","total_value":2761000.0,"total_display":"2,761,000.00","total_whole":"2,761,000","shares_owned_after":5783.0,"shares_owned_after_display":"5,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-09","filed_date":"2025-06-10","scope":"insider"},{"id":4836045,"accession":"0000950170-25-078552","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-078552","line_url":"/filing/0000950170-25-078552#line-4","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001805812","owner_name":"Jacobson Mark L.","owner_display_name":"Jacobson Mark L.","owner_url":"/insider/0001805812","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":103.45,"price_display":"103.45","price_state":"stated","total_value":2069000.0,"total_display":"2,069,000.00","total_whole":"2,069,000","shares_owned_after":5783.0,"shares_owned_after_display":"5,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-28","filed_date":"2025-05-28","scope":"insider"},{"id":4836038,"accession":"0000950170-25-078552","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-078552","line_url":"/filing/0000950170-25-078552#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001805812","owner_name":"Jacobson Mark L.","owner_display_name":"Jacobson Mark L.","owner_url":"/insider/0001805812","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20673.0,"shares_display":"20,673","price_per_share":104.66,"price_display":"104.66","price_state":"stated","total_value":2163636.18,"total_display":"2,163,636.18","total_whole":"2,163,636","shares_owned_after":5783.0,"shares_owned_after_display":"5,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-27","filed_date":"2025-05-28","scope":"insider"},{"id":2117384,"accession":"0000950170-24-094967","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-094967","line_url":"/filing/0000950170-24-094967#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001805812","owner_name":"Jacobson Mark L.","owner_display_name":"Jacobson Mark L.","owner_url":"/insider/0001805812","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47739.0,"shares_display":"47,739","price_per_share":84.26,"price_display":"84.26","price_state":"stated","total_value":4022488.14,"total_display":"4,022,488.14","total_whole":"4,022,488","shares_owned_after":5783.0,"shares_owned_after_display":"5,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-09","filed_date":"2024-08-09","scope":"insider"},{"id":2205232,"accession":"0000950170-24-066177","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-066177","line_url":"/filing/0000950170-24-066177#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001805812","owner_name":"Jacobson Mark L.","owner_display_name":"Jacobson Mark L.","owner_url":"/insider/0001805812","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7910.0,"shares_display":"7,910","price_per_share":74.3127,"price_display":"74.31","price_state":"stated","total_value":587813.457,"total_display":"587,813.46","total_whole":"587,813","shares_owned_after":5783.0,"shares_owned_after_display":"5,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-29","filed_date":"2024-05-29","scope":"insider"},{"id":2768969,"accession":"0000950170-24-039617","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-039617","line_url":"/filing/0000950170-24-039617#line-2","is_derivative":false,"issuer_cik":"0001579428","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001579428","owner_cik":"0001805812","owner_name":"Jacobson Mark L.","owner_display_name":"Jacobson Mark L.","owner_url":"/insider/0001805812","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24662.0,"shares_display":"24,662","price_per_share":77.242,"price_display":"77.24","price_state":"stated","total_value":1904942.204,"total_display":"1,904,942.20","total_whole":"1,904,942","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001579428","name":"Axsome Therapeutics, Inc.","url":"/issuer/0001579428","role":"Officer (Chief Operating Officer)","n_filings":9,"first_seen":"2024-04-01","last_seen":"2026-05-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001805812","retrieved_at":"2026-08-24T20:50:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}